Song Man-ki (second from the right in the front row) is answering questions about the novel coronavirus infection (Corona 19) vaccine at the Seoul Government Complex on the 18th. yunhap news
On the 29th, Dr. Man-gi Song of the International Vaccine Research Institute predicted that the supply of AstraZeneca vaccine, which is expected to be the first vaccine for coronavirus infection (Corona 19) in Korea, is going very well, so that it will be possible to quickly inoculate high-risk groups.
Dr. Song appeared at TBS Kim Eo-jun’s news factory on the same day and said, “In the case of AstraZeneca vaccine, we know that SK Bioscience has entered the production, but since it is self-produced, we expect to be able to secure some quantity.”
He added, “AstraZeneca vaccine is stored in a refrigerator and is very simple to use, so it will be very easy to inoculate in large quantities.”
When asked,’Do you think the introduction of the AstraZeneca vaccine will be an opportunity for the reversal of Corona 19 in Korea?’ Dr. Song said, “It is possible to inoculate necessary personnel, the elderly, and high-risk groups somewhat quickly.” I think there will be.” The AstraZeneca vaccine is expected to enter Korea around February next year.
Dr. Song said, “After the AstraZeneca vaccine comes in, Johnson & Johnson, Pfizer in the third quarter of next year, then the next Kobex vaccine will be available.” You must proceed with the vaccination to prevent confusion.”
“Vaccines can respond enough to mutant viruses”
A novel coronavirus infection (Corona 19) vaccine developed by AstraZeneca. Newsis
Dr. Song said that the general public cannot choose the vaccine they want when vaccinating, but all vaccines have been proven to be effective, so there is no need to worry.
He said, “(Vaccination) has a priority, so I know that it is not possible to choose a vaccine.” “The vaccines that are currently approved are the ones that have been determined to be effective by global regulatory agencies, so publicity or guidance is needed.”
When asked, “Which vaccine is more effective against the mutant virus in the UK?”, Dr. Song said, “(Pfizer or Moderna) is a synthetic method that is advantageous because it can be made quickly, but AstraZeneca is also developing a vaccine against the strain.” “AstraZeneca also has a mass production system method, so there is no big problem in responding,” he said.
However, Dr. Song said, “If such mutations continue to occur, all existing vaccines can become useless, so it is very important for the whole world to cooperate.” It is not that it is said that it is important that the world is safe.”
Ryuho reporter [email protected]
You can also view the news Naver Et edited by the Hankook Ilbo.
